FANJ
NAGE

Financial Architects (New Jersey)’s Niagen Bioscience NAGE Stock Holding History

Financial Architects (New Jersey)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$3K – 1643
2016
Q4 		$3K Hold
1,000
– – ﹤0.01% 1258
2016
Q3 		$3K Sell
1,000
-1,334
-57% -$4.9K ﹤0.01% 1280
2016
Q2 		$10K Buy
+2,334
New +$11K ﹤0.01% 989

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Financial Architects (New Jersey)'s NAGE Position: Q1 2017 in Review

Financial Architects (New Jersey) sold out of Niagen Bioscience (NAGE) in Q1 2017, closing a stake of 1,000 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in NAGE in Q2 2016 and held it in 3 quarters. The position peaked at $10K in Q2 2016. 46 funds tracked by Wall St. Rank hold NAGE as of Q1 2017.

  • Financial Architects (New Jersey) reported no remaining Niagen Bioscience position as of Q1 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 1,000 Niagen Bioscience shares in Q1 2017, an estimated $3K.
  • Financial Architects (New Jersey) first reported a position in Niagen Bioscience in Q2 2016 and held it in 3 quarters.
  • Financial Architects (New Jersey)'s Niagen Bioscience position peaked at $10K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2017, filed 26 Apr 2017.